Accu-Break Pharmaceuticals, Inc. Enters into a Product Development and License Agreement with Alembic Pharmaceuticals Limited
09:00 EDT 6 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Accu-Break Pharmaceuticals, Inc. (“ABP”) announced today that it has
entered into a development and license agreement with Alembic
Pharmaceuticals Limited of Gujarat, India to develop new brand products
that will use ABP’s...
Other Sources for this Article
Accu-Break Pharmaceuticals, Inc.
Geoff Green, 954-236-7351
Vice
President, Business Development & Clinical Affairs
g.green@accubreak.com
More From BioPortfolio on "Accu-Break Pharmaceuticals, Inc. Enters into a Product Development and License Agreement with Alembic Pharmaceuticals Limited"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
